Hatzis-Schoch Brent (CIK 0001637054)

Latest company ownership

Shares held
175,000
Last filed at
Jan 31, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 12, 2021 May 13, 2021 Black Diamond Therapeutics, Inc. Officer Sell 10.0 -4,078 -32.68% ✓ $111.8K
Apr 12, 2021 Apr 13, 2021 Black Diamond Therapeutics, Inc. Officer Sell 10.0 -4,078 -32.68% ✓ $102K
Mar 12, 2021 Mar 16, 2021 Black Diamond Therapeutics, Inc. Officer Sell 10.0 -4,078 -32.68% ✓ $107.5K
Feb 12, 2021 Feb 12, 2021 Black Diamond Therapeutics, Inc. Officer Sell 10.0 -4,078 -32.68% ✓ $111K
Jan 12, 2021 Jan 14, 2021 Black Diamond Therapeutics, Inc. Officer Sell 7.5 -11,578 -57.95% ✓ $394K
Dec 14, 2020 Dec 16, 2020 Black Diamond Therapeutics, Inc. Officer Sell 10.0 -4,078 -57.62% ✓ $142.5K
Nov 12, 2020 Nov 13, 2020 Black Diamond Therapeutics, Inc. Officer Sell 10.0 -4,078 -57.62% ✓ $138.6K
Oct 12, 2020 Oct 14, 2020 Black Diamond Therapeutics, Inc. Officer Sell 10.0 -4,078 -57.62% ✓ $133.3K
Sep 14, 2020 Sep 16, 2020 Black Diamond Therapeutics, Inc. Officer Sell 10.0 -4,078 -57.62% ✓ $126.6K
Feb 3, 2020 Feb 5, 2020 Black Diamond Therapeutics, Inc. Officer Buy 95.0 +3,000 100.00% ✗ $57K